Serum MUC-1 as a marker of disease status in multiple myeloma patients receiving thalidomide

Linda Mileshkin, H. M. Prince, J. F. Seymour, J. J. Biagi, Stefano Luminari, Massimo Federico, Luca Baldini

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)747-748
Number of pages2
JournalBritish Journal of Haematology
Issue number4
Publication statusPublished - Nov 2003


  • MUC-1
  • Multiple myeloma
  • Prognostic factor

ASJC Scopus subject areas

  • Hematology

Cite this